Interactions Between Amino Acid-Defined Major Histocompatibility Complex Class II Variants and Smoking in Seropositive Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Interactions Between Amino Acid-Defined Major Histocompatibility Complex Class II Variants and Smoking in Seropositive Rheumatoid Arthritis

Published:2015-09-23 Issue:10 Volume:67 Page:2611-2623
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Kim Kwangwoo¹,Jiang Xia²,Cui Jing³,Lu Bing⁴,Costenbader Karen H.⁴,Sparks Jeffrey A.⁴,Bang So-Young⁵,Lee Hye-Soon⁵,Okada Yukinori⁶,Raychaudhuri Soumya⁷,Alfredsson Lars²,Bae Sang-Cheol⁵,Klareskog Lars⁸,Karlson Elizabeth W.⁴

Affiliation:

1. Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and Broad Institute; Cambridge Massachusetts

2. Karolinska Institute; Stockholm Sweden

3. Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and Broad Institute; Cambridge Massachusetts

4. Brigham and Women's Hospital and Harvard Medical School; Boston Massachusetts

5. Hanyang University Hospital for Rheumatic Diseases; Seoul Republic of Korea

6. Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, Broad Institute, Cambridge, Massachusetts, Tokyo Medical and Dental University, Tokyo, Japan, and RIKEN Center for Integrative Medical Sciences; Yokohama Japan

7. Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, Broad Institute, Cambridge, Massachusetts, and Manchester Academic Health Sciences Centre; Manchester UK

8. Karolinska Institutet and Karolinska Hospital; Stockholm Sweden

Funder

The Swedish Epidemiological Investigation of Rheumatoid Arthritis

Swedish Medical Research Council

Swedish Council for Working Life and Social Research

King Gustaf V's 80-Year Foundation

Swedish Rheumatism Foundation

Stockholm County Council

Swedish insurer AFA

Innovative Medicines Initiative (BTCure)

The Nurses’ Health Study

NIH